Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Recruiting · NCT05654675 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
FDG PET/CT
What this trial is about
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are: * Is the new quantification method superior with respect to the method currently used in the clinic? * Does the new quantification method provide accurate assessment of the sugar consumption of tumours? Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients who receive an 18F FDG PET/CT scan as part of standard care
- Be competent and be 18 years of age or older
Exclusion criteria
- Diabetes (fasted blood glucose \> 7 mmol/L)
- Not fasted \> 4 hours
- Physical exercise within 24 hours
- Earlier treatment for carcinoma with radio/chemo-therapy
- Active inflammation (fever \> 38 degrees, CRP \> 5)
- Any condition or medical indication (such as claustrophobia) that indicates that the patient will not be able to lie still for the duration of the dynamic PET/CT examination
- Pregnant or breast feeding
Where it is running
1 location listed.
- Academisch ziekenhuis Maastricht - Maastricht, Limburg, Netherlands